» Articles » PMID: 32774064

Details Determining the Success in Establishing a Mouse Orthotopic Liver Transplantation Model

Overview
Specialty Gastroenterology
Date 2020 Aug 11
PMID 32774064
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Liver transplantation (LT) is currently the only effective treatment option for end-stage liver disease. The importance of animal models in transplantation is widely recognized among researchers. Because of the well-characterized mouse genome and the greater diversity and availability of both genetically modified animals and research reagents, mouse orthotopic LT (MOLT) has become an ideal model for the investigation of liver biology, tissue injury, regulation of alloimmunity and tolerance induction, and the pathogenesis of specific liver diseases. However, due to its complicated and technically demanding procedure, the model has merely been used by only a few research groups in the world for years. For a new learner, training lasting at least a couple of months or even years is required. Most of the investigators have emphasized the importance of elaborate techniques and dedicated instruments in establishing a MOLT model, but some details are often neglected. The nontechnical details are also significant, especially for researchers who have little experience in mouse microsurgery. Here, we review and summarize the crucial technical and nontechnical details in establishing the model of MOLT based on scientific articles and our experience in six aspects: animal selection, anesthesia, perioperative management, organ procurement, back-table preparation, and implantation surgery. We aim to enable research groups to shorten the learning curve and implement the mouse LT procedure with high technical success.

Citing Articles

Characterization and Proteomic Analyses of Proinflammatory Cytokines in a Mouse Model of Liver Transplant Rejection.

Li S, Li X, Chen X, Zhang J, Zhou G, Zhou L Oxid Med Cell Longev. 2022; 2022:5188584.

PMID: 35993024 PMC: 9391131. DOI: 10.1155/2022/5188584.


Potential correlation of allograft infiltrating group 2 innate lymphoid cells with acute rejection after liver transplantation.

Sun J, Zhou G, Li S, Chen X, Zhang J, Jiang Y Front Immunol. 2022; 13:953240.

PMID: 35967423 PMC: 9367675. DOI: 10.3389/fimmu.2022.953240.

References
1.
Oldani G, Lacotte S, Orci L, Delaune V, Slits F, Gex Q . Efficient nonarterialized mouse liver transplantation using 3-dimensional-printed instruments. Liver Transpl. 2016; 22(12):1688-1696. DOI: 10.1002/lt.24637. View

2.
Li D, Shi X, Li W, Du X, Wang G . Key Points in Establishing a Model of Mouse Liver Transplantation. Transplant Proc. 2015; 47(9):2683-9. DOI: 10.1016/j.transproceed.2015.07.031. View

3.
Kamada N, Calne R . Orthotopic liver transplantation in the rat. Technique using cuff for portal vein anastomosis and biliary drainage. Transplantation. 1979; 28(1):47-50. View

4.
Yoshida O, Kimura S, Dou L, Matta B, Yokota S, Ross M . DAP12 deficiency in liver allografts results in enhanced donor DC migration, augmented effector T cell responses and abrogation of transplant tolerance. Am J Transplant. 2014; 14(8):1791-805. PMC: 4107008. DOI: 10.1111/ajt.12757. View

5.
Steger U, Sawitzki B, Gassel A, Gassel H, Wood K . Impact of hepatic rearterialization on reperfusion injury and outcome after mouse liver transplantation. Transplantation. 2003; 76(2):327-32. DOI: 10.1097/01.TP.0000071521.36828.F7. View